-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M1ezWHK+RP1y3NRH5CdRfK2srxyY5DFYU+Vtfp77FRWfYmx7AFyEn937Iic8e9ir iUHDDNSqA8KlvjaVIxXuiw== 0000912057-02-032854.txt : 20020819 0000912057-02-032854.hdr.sgml : 20020819 20020819172541 ACCESSION NUMBER: 0000912057-02-032854 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020819 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20020819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLYKO BIOMEDICAL LTD CENTRAL INDEX KEY: 0000908401 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 680230537 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21994 FILM NUMBER: 02743135 BUSINESS ADDRESS: STREET 1: ATTENTION: CONTROLLER STREET 2: 11 PIMENTEL COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-884-6725 MAIL ADDRESS: STREET 1: ATTENTION: CONTROLLER STREET 2: 11 PIMENTEL COURT CITY: NOVATO STATE: CA ZIP: 94949 8-K 1 a2087768z8-k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2002 Glyko Biomedical Ltd. - -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Canada 000-21994 98-0195569 - ---------------------------- -------------------- --------------------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 199 Bay Street, Suite 2800 Toronto, Ontario, Canada M5L 1A9 - ---------------------------------------- ---------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (415) 884-6700 -------------- Not applicable - ------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) ITEM 4. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT. The Company has engaged KPMG LLP ("KPMG") as its new independent certifying accountants effective August 19, 2002. The decision to engage KPMG as the Company's new independent certifying accountants was approved by the Audit Committee of the Company's Board of Directors. During the fiscal years ended December 31, 2001 and 2000 and the interim period between December 31, 2001 and August 19, 2002, neither the Company nor anyone acting on its behalf consulted KPMG with respect to (i) the application of accounting principles to a specified transaction, either completed or proposed, or (ii) the type of audit opinion that might be rendered on the Company's consolidated financial statements, or any other matters or reportable events listed in Items 304(a)(2)(i) and (ii) of Regulation S-K. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. EXHIBITS. Not Applicable. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLYKO BIOMEDICAL LTD. Date: August 19, 2002 By: /s/ J. A. Kolada -------------------------------------- J. A. Kolada Secretary -----END PRIVACY-ENHANCED MESSAGE-----